Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

gallium Ga 68-WL12

A radiotracer composed of the programmed cell death-1 ligand 1 (PD-L1; cluster of differentiation 274; CD274)-binding peptide WL12 radiolabeled with the radionuclide gallium Ga 68, with potential PD-L1 imaging activity using positron emission tomography (PET). Upon administration of gallium Ga 68-WL12, the WL12 moiety targets and binds to PD-L1 expressed on certain tumor cells. Upon uptake and PET imaging, the radioisotope moiety can be visualized and the extent of PD-L1 expression can be assessed. This may be used to predict the therapeutic response to PD-L1-targeting agents.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	[68Ga]-WL12 68Ga-WL12 gallium Ga 68-labeled WL12

gallium Ga 68-WL12

Search NCI's Drug Dictionary